Care mothers, this article may interest you. It seems that the much hyped Tamiflu brings more complications than advantages in case of influenza A.
Via Diario La Nacion of Buenos Aires
A British study found that oseltamivir, the generic drug used to attack the flu is not recommended to treat children under 12 years.
As described by the British Medical Journal, a group of experts from the University of Oxford found that routine prescription of drugs such as Tamiflu, from Roche, or Relenza, GlaxoSmithKline, it would be inadvisable, because no clear evidence to prevent complications of the disease and, conversely, its potential side effects may outweigh any benefits.
The study, based on an analysis of data from comparative trials of neuraminidase inhibitors (enzyme present in the flu virus) in children, says that Tamiflu can cause vomiting, diarrhea, dehydration and complications neuropsychiatric. Made about 1766
children up to 12 years, the study is before the current influenza pandemic, but suggests, however, that Tamiflu has little or no effect on asthma attacks that could affect a patient or the increase in flu-like symptoms and increased otitis.
Dr. Carl Henegar, a general practitioner and expert John Radcliffe Hospital in Oxford, one of the authors of the study, believes that the current policy of prescribing Tamiflu for a relatively benign disease is "a wrong strategy." His colleague, Matthew Thompson, also of Oxford University, said although the study was not related to the current pandemic flu, "there is no reason to believe that the conclusions would not be the same."
In Argentina, the Ministry of Health distributed to date approximately two million treatments, consisting of a box with ten tablets of oseltamivir. There are no data on the age group in which they were supplied but at the beginning of the emergency, most patients were school-age children, according to the health agency.
During the contingency phase of the disease, about 40 schools were closed for cases of influenza A and was given the antiviral drug to patients not only suspects but also the "contacts", ie children who were partners of the affected or who had shared the classroom.
British medical team also concluded that the mass prescription of oseltamivir, in some cases as a preventive measure, only reduces the transmission in a modest 8 percent.
the full story here:
Alert health / study questions the antiviral against influenza A discourage children apply Tamiflu
Experts from the University of Oxford warned about its use, arguing that the adverse effects outweigh any benefits
0 comments:
Post a Comment